The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats

K. Mishima, K. Iwasaki, H. Tsukikawa, Y. Matsumoto, N. Egashira, Koji Abe, T. Egawa, M. Fujiwara

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

We investigated the relationship between the induction of spatial cognition impairment in the 8-arm radial maze task and regional changes (ventral hippocampus (VH), dorsal hippocampus, frontal cortex, and basolateral amygdala nucleus) in brain acetylcholine (ACh) release using microdialysis in rats treated with muscarinic (M) receptor antagonists. In a behavioral study, two M1 antagonists, scopolamine (0.5 mg/kg, i.p. and 20 μg, i.c.v.) and pirenzepine (80 μg, i.c.v.) but not an M2 antagonist, AF-DX116 (40 - 80 μg, i.c.v.), disrupted spatial cognition in the 8-arm radial maze task. In brain microdialysis with Ringer's solution containing 0.1 mM eserine sulfate, scopolamine and AF-DX116, but not pirenzepine, increased ACh release in the VH. Moreover, in the bilateral injection of scopolamine (2 μg/side), the VH dorsomedial thalamus nucleus were important regions for scopolamine-induced impairment of spatial cognition. A simultaneous determination of the behavioral changes revealed that scopolamine (0.5 mg/kg, i.p.) markedly decreased the ACh contents and also increased the ACh release in all regions tested. Especially, the changes in the ACh release of the VH closely paralleled the induction of the scopolamine-induced impairment of spatial cognition. These results suggest that the blocking balance between M1 and M'2 muscarinic receptor in the VH therefore plays a major role in the spatial cognition impairment induced by scopolamine in the 8-arm radial maze task.

Original languageEnglish
Pages (from-to)163-173
Number of pages11
JournalJapanese Journal of Pharmacology
Volume84
Issue number2
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Scopolamine Hydrobromide
Cognition
Acetylcholine
Hippocampus
Pirenzepine
Microdialysis
Muscarinic Receptors
Mediodorsal Thalamic Nucleus
Physostigmine
Brain
Frontal Lobe
Thalamus
Sulfates
Injections

Keywords

  • 8-Arm radial maze task
  • Acetylcholine release
  • Scopolamine
  • Spatial cognition
  • Ventral hippocampus

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats. / Mishima, K.; Iwasaki, K.; Tsukikawa, H.; Matsumoto, Y.; Egashira, N.; Abe, Koji; Egawa, T.; Fujiwara, M.

In: Japanese Journal of Pharmacology, Vol. 84, No. 2, 2000, p. 163-173.

Research output: Contribution to journalArticle

Mishima, K. ; Iwasaki, K. ; Tsukikawa, H. ; Matsumoto, Y. ; Egashira, N. ; Abe, Koji ; Egawa, T. ; Fujiwara, M. / The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats. In: Japanese Journal of Pharmacology. 2000 ; Vol. 84, No. 2. pp. 163-173.
@article{8d215a97e383469e8b29c5796e0baf37,
title = "The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats",
abstract = "We investigated the relationship between the induction of spatial cognition impairment in the 8-arm radial maze task and regional changes (ventral hippocampus (VH), dorsal hippocampus, frontal cortex, and basolateral amygdala nucleus) in brain acetylcholine (ACh) release using microdialysis in rats treated with muscarinic (M) receptor antagonists. In a behavioral study, two M1 antagonists, scopolamine (0.5 mg/kg, i.p. and 20 μg, i.c.v.) and pirenzepine (80 μg, i.c.v.) but not an M2 antagonist, AF-DX116 (40 - 80 μg, i.c.v.), disrupted spatial cognition in the 8-arm radial maze task. In brain microdialysis with Ringer's solution containing 0.1 mM eserine sulfate, scopolamine and AF-DX116, but not pirenzepine, increased ACh release in the VH. Moreover, in the bilateral injection of scopolamine (2 μg/side), the VH dorsomedial thalamus nucleus were important regions for scopolamine-induced impairment of spatial cognition. A simultaneous determination of the behavioral changes revealed that scopolamine (0.5 mg/kg, i.p.) markedly decreased the ACh contents and also increased the ACh release in all regions tested. Especially, the changes in the ACh release of the VH closely paralleled the induction of the scopolamine-induced impairment of spatial cognition. These results suggest that the blocking balance between M1 and M'2 muscarinic receptor in the VH therefore plays a major role in the spatial cognition impairment induced by scopolamine in the 8-arm radial maze task.",
keywords = "8-Arm radial maze task, Acetylcholine release, Scopolamine, Spatial cognition, Ventral hippocampus",
author = "K. Mishima and K. Iwasaki and H. Tsukikawa and Y. Matsumoto and N. Egashira and Koji Abe and T. Egawa and M. Fujiwara",
year = "2000",
doi = "10.1254/jjp.84.163",
language = "English",
volume = "84",
pages = "163--173",
journal = "Japanese Journal of Pharmacology",
issn = "0021-5198",
publisher = "Japanese Pharmacological Society",
number = "2",

}

TY - JOUR

T1 - The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats

AU - Mishima, K.

AU - Iwasaki, K.

AU - Tsukikawa, H.

AU - Matsumoto, Y.

AU - Egashira, N.

AU - Abe, Koji

AU - Egawa, T.

AU - Fujiwara, M.

PY - 2000

Y1 - 2000

N2 - We investigated the relationship between the induction of spatial cognition impairment in the 8-arm radial maze task and regional changes (ventral hippocampus (VH), dorsal hippocampus, frontal cortex, and basolateral amygdala nucleus) in brain acetylcholine (ACh) release using microdialysis in rats treated with muscarinic (M) receptor antagonists. In a behavioral study, two M1 antagonists, scopolamine (0.5 mg/kg, i.p. and 20 μg, i.c.v.) and pirenzepine (80 μg, i.c.v.) but not an M2 antagonist, AF-DX116 (40 - 80 μg, i.c.v.), disrupted spatial cognition in the 8-arm radial maze task. In brain microdialysis with Ringer's solution containing 0.1 mM eserine sulfate, scopolamine and AF-DX116, but not pirenzepine, increased ACh release in the VH. Moreover, in the bilateral injection of scopolamine (2 μg/side), the VH dorsomedial thalamus nucleus were important regions for scopolamine-induced impairment of spatial cognition. A simultaneous determination of the behavioral changes revealed that scopolamine (0.5 mg/kg, i.p.) markedly decreased the ACh contents and also increased the ACh release in all regions tested. Especially, the changes in the ACh release of the VH closely paralleled the induction of the scopolamine-induced impairment of spatial cognition. These results suggest that the blocking balance between M1 and M'2 muscarinic receptor in the VH therefore plays a major role in the spatial cognition impairment induced by scopolamine in the 8-arm radial maze task.

AB - We investigated the relationship between the induction of spatial cognition impairment in the 8-arm radial maze task and regional changes (ventral hippocampus (VH), dorsal hippocampus, frontal cortex, and basolateral amygdala nucleus) in brain acetylcholine (ACh) release using microdialysis in rats treated with muscarinic (M) receptor antagonists. In a behavioral study, two M1 antagonists, scopolamine (0.5 mg/kg, i.p. and 20 μg, i.c.v.) and pirenzepine (80 μg, i.c.v.) but not an M2 antagonist, AF-DX116 (40 - 80 μg, i.c.v.), disrupted spatial cognition in the 8-arm radial maze task. In brain microdialysis with Ringer's solution containing 0.1 mM eserine sulfate, scopolamine and AF-DX116, but not pirenzepine, increased ACh release in the VH. Moreover, in the bilateral injection of scopolamine (2 μg/side), the VH dorsomedial thalamus nucleus were important regions for scopolamine-induced impairment of spatial cognition. A simultaneous determination of the behavioral changes revealed that scopolamine (0.5 mg/kg, i.p.) markedly decreased the ACh contents and also increased the ACh release in all regions tested. Especially, the changes in the ACh release of the VH closely paralleled the induction of the scopolamine-induced impairment of spatial cognition. These results suggest that the blocking balance between M1 and M'2 muscarinic receptor in the VH therefore plays a major role in the spatial cognition impairment induced by scopolamine in the 8-arm radial maze task.

KW - 8-Arm radial maze task

KW - Acetylcholine release

KW - Scopolamine

KW - Spatial cognition

KW - Ventral hippocampus

UR - http://www.scopus.com/inward/record.url?scp=0033762421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033762421&partnerID=8YFLogxK

U2 - 10.1254/jjp.84.163

DO - 10.1254/jjp.84.163

M3 - Article

C2 - 11128039

AN - SCOPUS:0033762421

VL - 84

SP - 163

EP - 173

JO - Japanese Journal of Pharmacology

JF - Japanese Journal of Pharmacology

SN - 0021-5198

IS - 2

ER -